The US government has initiated investigations into pharmaceutical and semiconductor imports, signaling a potential wave of new tariffs that could significantly impact both industries. The Trump administration is reportedly nearing a plan to impose tariffs on pharmaceuticals, with commerce officials suggesting that these tariffs could be implemented within the next month or two. Trump has touted that these tariffs will encourage domestic production, although experts warn they may lead to heightened drug costs and exacerbate existing shortages. The investigations fall under Section 232, which allows for actions to protect national security, indicating that the administration is taking a firm stance against these imports. Global pharmaceutical companies are bracing for the announced tariffs, which could complicate access to essential medicines for millions in the US.